TIBER CREEK GROUP for CIGNA CORPORATION AND SUBSIDIARIES
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to pharmacy and prescription drug pricing; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169); Issues relating to implementation of the No Surprises Act (PL 116-260).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAN BEUKELMAN | — |
| NIKOLE BURROUGHS | — |
| ANDREW MCKECHNIE | — |
| JOSEPH RUSSO | — |
| JOHN KIRKLAND TWOMEY | — |
Defense DEF
Pharmacy issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAN BEUKELMAN | — |
| NIKOLE BURROUGHS | — |
| ANDREW MCKECHNIE | — |
| JOSEPH RUSSO | — |
| JOHN KIRKLAND TWOMEY | — |
Pharmacy PHA
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAN BEUKELMAN | — |
| NIKOLE BURROUGHS | — |
| ANDREW MCKECHNIE | — |
| JOSEPH RUSSO | — |
| JOHN KIRKLAND TWOMEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.